title: Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
abstract: OBJECTIVE
  To clarify the clinical significance of tumor necrosis factor (TNF) receptors in patients with myeloperoxidase (MPO)-anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, we evaluated the cell surface expression of TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2).
  
  
  METHODS
  43 patients with MPO-ANCA-associated vasculitis, 16 patients with chronic renal failure, 10 patients with sepsis, 15 patients with systemic lupus erythematosus, and 18 healthy controls were enrolled in this study, and the surface expression levels of TNFR1, TNFR2, CD63, and CD64 on granulocytes were assessed. In 21 patients with MPO-ANCA-associated vasculitis, soluble TNFR1 (sTNFR1), soluble TNFR2(sTNFR2), and TNF-alpha in the serum were also measured.
  
  
  RESULTS
  The surface expression levels of TNFR1 and TNFR2 on granulocytes were significantly higher in patients with MPO-ANCA-associated vasculitis than in the healthy controls, and positively correlated with the Birmingham Vasculitis Activity Score (BVAS). The levels of sTNFR1, sTNFR2, and TNF-alpha in the serum were also significantly higher in patients with MPO-ANCA-associated vasculitis than in the healthy controls. Serum levels of sTNFR1 and sTNFR2 correlated with serum creatinine, while the surface expression of TNFR1 and TNFR2 on the granulocytes did not. There was no significant correlation between the BVAS and CD63 or BVAS and CD64.
  
  
  CONCLUSIONS
  The surface expression levels of TNFR1 and TNFR2 on granulocytes were upregulated in patients with MPO-ANCA-associated vasculitis and reflected disease activity.
authors.affiliation: Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. mhase@fujita-hu.ac.jp
authors.forename: Midori
authors.initials: M
authors.lastname: Hasegawa
authors.forename: Chikako
authors.initials: C
authors.lastname: Nishii
authors.forename: Atsushi
authors.initials: A
authors.lastname: Ohashi
authors.forename: Makoto
authors.initials: M
authors.lastname: Tomita
authors.forename: Shigeru
authors.initials: S
authors.lastname: Nakai
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Murakami
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Nabeshima
authors.forename: Yoshirou
authors.initials: Y
authors.lastname: Fujita
authors.forename: Junichi
authors.initials: J
authors.lastname: Ishii
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Hiki
authors.forename: Satoshi
authors.initials: S
authors.lastname: Sugiyama
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000097:blood* / Q000175:diagnosis / Q000201:enzymology; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D005260:Female; D005786:Gene Expression Regulation; D006098:Granulocytes / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009195:Peroxidase / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor / Q000096:biosynthesis* / Q000097:blood / Q000235:genetics*; D055815:Young Adult
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D015415:Biomarkers; D018124:Receptors, Tumor Necrosis Factor; D009195:Peroxidase